|
1
|
Ediriweera MK, Tennekoon KH and Samarakoon
SR: A review on ethnopharmacological applications, pharmacological
activities, and bioactive compounds of Mangifera indica
(mango). Evid Based Complement Alternat Med.
2017(6949835)2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Yadav D and Singh S: Mango: History origin
and distribution. J Pharmacogn Phytochem. 6:1257–1262. 2017.
|
|
3
|
Maldonado-Celis ME, Yahia EM, Bedoya R,
Landázuri P, Loango N, Aguillón J, Restrepo B and Guerrero Ospina
JC: Chemical composition of mango (Mangifera indica L.)
fruit: Nutritional and phytochemical compounds. Front Plant Sci.
10(1073)2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Weerarathne WAPG, Samarajeewa PK and
Nilanthi RMR: Genetic diversity of etamba in Sri Lanka. J Trop Agri
Res Ext. 8:107–112. 2005.
|
|
5
|
IUCN. The IUCN Red List of Threatened
Species. Version 2021-3. 2021. https://www.iucnredlist.org/species/31400/9630295.
Accessed January 21, 2022.
|
|
6
|
Ediriweera MK, Tennekoon KH and Samarakoon
SR: Emerging role of histone deacetylase inhibitors as
anti-breast-cancer agents. Drug Discov Today. 24:685–702.
2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Thakur VS, Deb G, Babcook MA and Gupta S:
Plant phytochemicals as epigenetic modulators: Role in cancer
chemoprevention. AAPS J. 16:151–163. 2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ghasemi S: Cancer's epigenetic drugs:
Where are they in the cancer medicines? Pharmacogenomics J.
20:367–379. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Shankar E, Kanwal R, Candamo M and Gupta
S: Dietary phytochemicals as epigenetic modifiers in cancer:
Promise and challenges. Semin Cancer Biol. 40-41:82–99.
2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Princwill-Ogbonna IL, Ogbonna PC and
Ogujiofor IB: Proximate composition, vitamin, mineral and
biologically active compounds levels in leaves of Mangifera
indica (Mango), Persea Americana (Avocado pea), and
Annona muricata (Sour Sop). J Appl Sci Environ Manage.
23(65)2019.
|
|
11
|
Dhital KS: Phytochemical screening and
antioxidant activities of Mangifera indica leaves grown in
temperate region of the Nepal. J Pharmacogn Phytochem. 6:205–209.
2017.
|
|
12
|
Vazquez-Olivo G, Antunes-Ricardo M,
Gutiérrez-Uribe JA, Osuna-Enciso T, León-Félix J and Heredia JB:
Cellular antioxidant activity and in vitro intestinal permeability
of phenolic compounds from four varieties of mango bark
(Mangifera indica L.). J Sci Food Agric. 99:3481–3489.
2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Khumpook T, Saenphet S, Tragoolpua Y and
Saenphet K: Anti-inflammatory and antioxidant activity of Thai
mango (Mangifera indica Linn.) leaf extracts. Comp Clin
Path. 28:157–164. 2019.
|
|
14
|
John OR, Yahaya AA and Emmanuel A: Aqueous
ethanolic extract of Mangifera indica stem bark effect on
the biochemical and haematological parameters of albino rats. Arch
Appl Sci Res. 4:1618–1622. 2012.
|
|
15
|
Al Omairi NE, Radwan OK, Alzahrani YA and
Kassab RB: Neuroprotective efficiency of Mangifera indica
leaves extract on cadmium-induced cortical damage in rats. Metab
Brain Dis. 33:1121–1130. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wattanathorn J, Muchimapura S, Thukham-Mee
W, Ingkaninan K and Wittaya-Areekul S: Mangifera indica
Fruit extract improves memory impairment, cholinergic dysfunction,
and oxidative stress damage in animal model of mild cognitive
impairment. Oxid Med Cell Longev. 2014(132097)2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kuganesan A, Thiripuranathar G, Navaratne
A and Paranagama P: Antioxidant and anti-inflammatory activities of
peels, pulps and seed kernels of three common mango (Mangifera
indical L.) varieties in Sri Lanka. Int. J Pharm Sci Res.
8:70–78. 2017.
|
|
18
|
Hassan M, Khan S, Shaikat A, Hossain M,
Hoque M, Ullah M and Islam S: Analgesic and anti-inflammatory
effects of ethanol extracted leaves of selected medicinal plants in
animal model. Vet World. 6:68–71. 2013.
|
|
19
|
Márquez L: Anti-inflammatory effects of
Mangifera indica L. extract in a model of colitis. World J
Gastroenterol. 16:4922–4931. 2010.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kim H, Krenek KA, Fang C, Minamoto Y,
Markel ME, Suchodolski JS, Talcott ST and Mertens-Talcott SU:
Polyphenolic derivatives from mango (Mangifera indica L.)
modulate fecal microbiome, short-chain fatty acids production and
the HDAC1/AMPK/LC3 axis in rats with DSS-induced colitis. J Funct
Foods. 48:243–251. 2018.
|
|
21
|
Márquez L, Pérez-Nievas BG, Gárate I,
García-Bueno B, Madrigal JL, Menchén L, Garrido G and Leza JC:
Anti-inflammatory effects of Mangifera indica L. extract in
a model of colitis. World J Gastroenterol. 16:4922–4931.
2010.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Perpétuo GF and Salgado JM: Effect of
mango (Mangifera indica, L.) ingestion on blood glucose
levels of normal and diabetic rats. Plant Foods Hum Nutr. 58:1–12.
2003.
|
|
23
|
Saleem M, Tanvir M, Akhtar MF, Iqbal M and
Saleem A: Antidiabetic potential of Mangifera indica L. cv.
Anwar Ratol leaves: Medicinal application of food wastes. Medicina
(Kaunas). 55(353)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Brito LF, Gontijo DC, Toledo RCL, Barcelos
RM, de Oliveira AB, Brandão GC, de Sousa LP, Ribeiro SMR, Leite
JPV, Fietto LG and de Queiroz JH: Mangifera indica leaves
extract and mangiferin modulate CB1 and PPARγ receptors and others
markers associated with obesity. J Funct Foods. 56:74–83. 2019.
|
|
25
|
Gondi M and Prasada Rao UJS: Ethanol
extract of mango (Mangifera indica L.) peel inhibits
α-amylase and α-glucosidase activities, and ameliorates diabetes
related biochemical parameters in streptozotocin (STZ)-induced
diabetic rats. J Food Sci Technol. 52:7883–7893. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Narasimhan A, Chinnaiyan M and Karundevi
B: Ferulic acid exerts its antidiabetic effect by modulating
insulin-signalling molecules in the liver of high-fat diet and
fructose-induced type-2 diabetic adult male rat. Appl Physiol Nutr
Metab. 40:769–781. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Moreno DA, Ripoll C, Ilic N, Poulev A,
Aubin C and Raskin I: Inhibition of lipid metabolic enzymes using
Mangifera indica extracts. J Food Agric Environ. 4:21–26.
2006.
|
|
28
|
Barnes RC, Kim H, Fang C, Bennett W, Nemec
M, Sirven MA, Suchodolski JS, Deutz N, Britton RA, Mertens-Talcott
SU and Talcott ST: Body mass index as a determinant of systemic
exposure to gallotannin metabolites during 6-week consumption of
mango (Mangifera indica L.) and modulation of intestinal
Microbiota in lean and obese individuals. Mol Nutr Food Res.
63(1800512)2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hannan A, Asghar S, Naeem T, Ikram Ullah
M, Ahmed I, Aneela S and Hussain S: Antibacterial effect of mango
(Mangifera indica Linn.) leaf extract against antibiotic
sensitive and multi-drug resistant Salmonella typhi. Pak J Pharm
Sci. 26:715–719. 2013.PubMed/NCBI
|
|
30
|
Manzur AG, Sm Junior V, Morais-Costa F,
Mariano EG, Careli RT, da Silva LM, Coelho SG, de Almeida AC and
Duarte ER: Extract of Mangifera indica L. leaves may reduce
biofilms of Staphylococcus spp. in stainless steel and
teatcup rubbers. Food Sci Technol Int. 26:11–20. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Mushore J and Matuvhunye M: Antibacterial
properties of Mangifera indica on Staphylococcus
aureus. Afr J Clin Exp Microbiol. 14:62–74. 2013.
|
|
32
|
Umamahesh K, Ramesh B, Kumar BV and Reddy
OV: In vitro anti-oxidant, anti-microbial and anti-inflammatory
activities of five Indian cultivars of mango (Mangifera
indica L.) fruit peel extracts. J Herb Med Pharmacol.
8:238–247. 2019.
|
|
33
|
Noratto GD, Bertoldi MC, Krenek K, Talcott
ST, Stringheta PC and Mertens-Talcott SU: Anticarcinogenic effects
of polyphenolics from mango (Mangifera indica) Varieties. J
Agric Food Chem. 58:4104–4112. 2010.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Fitriasih F, Komariyah SM, Sandra F,
Pratiwi N and Hidayati DN: Mangifera indica L. leaves
extract induced intrinsic apoptotic pathway in MCF-7 cells by
decreasing Bcl-2 expression and inducing Bax expression. Indones J
Cancer Chemoprevention. 10(1)2019.
|
|
35
|
Arbizu-Berrocal SH, Kim H, Fang C, Krenek
KA, Talcott ST and Mertens-Talcott SU: Polyphenols from mango
(Mangifera indica L.) modulate PI3K/AKT/mTOR-associated
micro-RNAs and reduce inflammation in non-cancer and induce cell
death in breast cancer cells. J Funct Foods. 55:9–16. 2019.
|
|
36
|
Abdullah AS, Mohammed A, Rasedee A and
Mirghani M: Oxidative stress-mediated apoptosis induced by
ethanolic mango seed extract in cultured estrogen receptor positive
breast cancer MCF-7 cells. Int J Mol Sci. 16:3528–3536.
2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Chieli E, Romiti N, Rodeiro I and Garrido
G: In vitro effects of Mangifera indica and polyphenols
derived on ABCB1/P-glycoprotein activity. Food Chem Toxicol.
47:2703–2710. 2009.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Ediriweera MK, Tennekoon KH and Samarakoon
SR: Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer:
Biological and therapeutic significance. Semin Cancer Biol.
59:147–160. 2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Banerjee N, Kim H, Krenek K, Talcott ST
and Mertens-Talcott SU: Mango polyphenolics suppressed tumor growth
in breast cancer xenografts in mice: Role of the PI3K/AKT pathway
and associated microRNAs. Nutr Res. 35:744–751. 2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Ediriweera MK, Tennekoon KH, Samarakoon
SR, Thabrew I and Dilip de Silva E: A study of the potential
anticancer activity of Mangifera zeylanica bark: Evaluation
of cytotoxic and apoptotic effects of the hexane extract and
bioassay-guided fractionation to identify phytochemical
constituents. Oncol Lett. 11:1335–1344. 2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Ediriweera MK, Tennekoon KH, Adhikari A,
Samarakoon SR, Thabrew I and de Silva ED: New halogenated
constituents from Mangifera zeylanica Hook.f. and their potential
anti-cancer effects in breast and ovarian cancer cells. J
Ethnopharmacol. 189:165–174. 2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Ediriweera MK, Tennekoon KH, Samarakoon
SR, Adhikari A, Thabrew I and Dilip de Silva E: Isolation of a new
resorcinolic lipid from Mangifera zeylanica Hook.f. bark and its
cytotoxic and apoptotic potential. Biomed Pharmacother. 89:194–200.
2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Ediriweera MK, Tennekoon KH, Samarakoon
SR, Thabrew I and De Silva ED: Induction of apoptosis in MCF-7
breast cancer cells by Sri Lankan endemic mango (Mangifera
zeylanica) fruit peel through oxidative stress and analysis of its
phytochemical constituents: Anticancer effects of Mangifera
zeylanica Peel. J Food Biochem. 41(e12294)2017.
|
|
44
|
Lauricella M, Lo Galbo V, Cernigliaro C,
Maggio A, Palumbo Piccionello A, Calvaruso G, Carlisi D, Emanuele
S, Giuliano M and D'Anneo A: The Anti-cancer effect of Mangifera
indica L. Peel extract is associated to γH2AX-mediated
apoptosis in colon cancer cells. Antioxidants (Basel).
8(422)2019.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Abdullah AS, Mohammed AS, Abdullah R,
Mirghani ME and Al-Qubaisi M: Cytotoxic effects of Mangifera
indica L. kernel extract on human breast cancer (MCF-7 and
MDA-MB-231 cell lines) and bioactive constituents in the crude
extract. BMC Complement Altern Med. 14(119)2014.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Yap KM, Sekar M, Seow JL, Gan SH, Bonam
SR, Rani NNIM, Lum PT, Subramaniyan V, Wu YS, Fuloria NK and
Fuloria S: Mangifera indica (Mango): A promising medicinal
plant for breast cancer therapy and understanding its potential
mechanisms of action. Breast Cancer (Dove Med Press). 13:471–503.
2021.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Ayatollahi A, Rahmati J, Salimi A and
Pourahmad J: A comparison of cytotoxic effects of Mangifera
indica L. and Juglans RegiaAqueous extract on human
chronic Lymphocytic leukemia. Iran J Pharm Res. 18:1843–1853.
2019.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Hu H, Zhao Q, Pang Z, Xie J, Lin L and Yao
Q: Optimization extraction, characterization and anticancer
activities of polysaccharides from mango pomace. Int J Biol
Macromol. 117:1314–1325. 2018.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Shaban NZ, Hegazy WA, Abdel-Rahman SM,
Awed OM and Khalil SA: Potential effect of Olea europea
leaves, Sonchus oleraceus leaves and Mangifera indica
peel extracts on aromatase activity in human placental microsomes
and CYP19A1 expression in MCF-7 cell line: Comparative study. Cell
Mol Biol (Noisy-le-grand). 62:11–19. 2016.PubMed/NCBI
|
|
50
|
Taing MW, Pierson JT, Shaw PN, Dietzgen
RG, Roberts-Thomson SJ, Gidley MJ and Monteith GR: Mango fruit
extracts differentially affect proliferation and intracellular
calcium signalling in MCF-7 human breast cancer cells. J Chem.
2015(613268)2015.
|
|
51
|
Kim H, Banerjee N, Barnes RC, Pfent CM,
Talcott ST, Dashwood RH and Mertens-Talcott SU: Mango polyphenolics
reduce inflammation in intestinal colitis-involvement of the
miR-126/PI3K/AKT/mTOR axis in vitro and in vivo: Mango
polyphenolics suppress colitis. Mol Carcinog. 56:197–207.
2017.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Villas Boas GR, Rodrigues Lemos JM, de
Oliveira MW, dos Santos RC, Stefanello da Silveira AP, Barbieri
Bacha F, Ito CNA, Bortolotte Cornelius E, Brioli Lima F, Sachilarid
Rodrigues AM, et al: Aqueous extract from Mangifera indica
Linn. (Anacardiaceae) leaves exerts long-term hypoglycemic effect,
increases insulin sensitivity and plasma insulin levels on diabetic
Wistar rats. PLoS One. 15(e0227105)2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Estuningtyas A, Setiabudy R, Wahidiyat P
and Freisleben HJ: The role of mangiferin in the prevention of
experimentally induced iron overload in an animal model. Drug Res
(Stuttg). 69:234–240. 2019.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Sahu AK, Verma VK, Mutneja E, Malik S, Nag
TC, Dinda AK, Arya DS and Bhatia J: Mangiferin attenuates
cisplatin-induced acute kidney injury in rats mediating modulation
of MAPK pathway. Mol Cell Biochem. 452:141–152. 2019.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Lim YC, Lee SH, Song MH, Yamaguchi K, Yoon
JH, Choi EC and Baek SJ: Growth inhibition and apoptosis by
(-)-epicatechin gallate are mediated by cyclin D1 suppression in
head and neck squamous carcinoma cells. Eur J Cancer. 42:3260–3266.
2006.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Coelho EM, de Souza MEAO, Corrêa LC, Viana
AC, de Azevêdo LC and dos Santos Lima M: Bioactive compounds and
antioxidant activity of mango peel liqueurs (Mangifera
indica L.) produced by different methods of maceration.
Antioxidants (Basel). 8(102)2019.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Abbasi AM, Guo X, Fu X, Zhou L, Chen Y,
Zhu Y, Yan H and Liu RH: Comparative assessment of phenolic content
and in vitro antioxidant capacity in the pulp and peel of mango
cultivars. Int J Mol Sci. 16:13507–13527. 2015.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Hou N, Liu N, Han J, Yan Y and Li J:
Chlorogenic acid induces reactive oxygen species generation and
inhibits the viability of human colon cancer cells. Anticancer
Drugs. 28:59–65. 2017.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Gao J, Yu H, Guo W, Kong Y, Gu L, Li Q,
Yang S, Zhang Y and Wang Y: The anticancer effects of ferulic acid
is associated with induction of cell cycle arrest and autophagy in
cervical cancer cells. Cancer Cell Int. 18(102)2018.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Sun G, Zhang S, Xie Y, Zhang Z and Zhao W:
Gallic acid as a selective anticancer agent that induces apoptosis
in SMMC-7721 human hepatocellular carcinoma cells. Oncol Lett.
11:150–158. 2016.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Wang B, Shen J, Wang Z, Liu J, Ning Z and
Hu M: Isomangiferin, a novel potent vascular endothelial growth
factor receptor 2 kinase inhibitor, suppresses breast cancer
growth, metastasis and angiogenesis. J Breast Cancer. 21:11–20.
2018.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Burmistrova O, Quintana J, Díaz JG and
Estévez F: Astragalin heptaacetate-induced cell death in human
leukemia cells is dependent on caspases and activates the MAPK
pathway. Cancer Lett. 309:71–77. 2011.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Peng ZG, Yao YB, Yang J, Tang YL and Huang
X: Mangiferin induces cell cycle arrest at G2/M phase through
ATR-Chk1 pathway in HL-60 leukemia cells. Genet Mol Res.
14:4989–5002. 2015.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Peng ZG, Luo J, Xia LH, Chen Y and Song
SJ: CML cell line K562 cell apoptosis induced by mangiferin.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 12:590–594. 2004.PubMed/NCBI(In Chinese).
|
|
65
|
Zou B, Wang H, Liu Y, Qi P, Lei T, Sun M
and Wang Y: Mangiferin induces apoptosis in human ovarian
adenocarcinoma OVCAR3 cells via the regulation of Notch3. Oncol
Rep. 38:1431–1441. 2017.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Mohan CG, Deepak M, Viswanatha GL, Savinay
G, Hanumantharaju V, Rajendra CE and Halemani PD: Anti-oxidant and
anti-inflammatory activity of leaf extracts and fractions of
Mangifera indica. Asian Pac J Trop Med. 6:311–314.
2013.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Shen X, Si Y, Wang Z, Wang J, Guo Y and
Zhang X: Quercetin inhibits the growth of human gastric cancer stem
cells by inducing mitochondrial-dependent apoptosis through the
inhibition of PI3K/Akt signaling. Int J Mol Med. 38:619–626.
2016.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Srivastava S, Somasagara RR, Hegde M,
Nishana M, Tadi SK, Srivastava M, Choudhary B and Raghavan SC:
Quercetin, a natural flavonoid interacts with DNA, arrests cell
cycle and causes tumor regression by activating mitochondrial
pathway of apoptosis. Sci Rep. 6(24049)2016.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Pardede A and Koketsu M: Antioxidant and
antileukemic activity of chemical components from bark of Mangifera
casturi. Comp Clin Path. 26:499–504. 2017.
|
|
70
|
Wang Y, Hong D, Qian Y, Tu X, Wang K, Yang
X, Shao S, Kong X, Lou Z and Jin L: Lupeol inhibits growth and
migration in two human colorectal cancer cell lines by suppression
of Wnt-β-catenin pathway. Onco Targets Ther. 11:7987–799.
2018.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Ahmad S, Sukari MA, Ismail N, Ismail IS,
Abdul AB, Abu Bakar MF, Kifli N and Ee GC: Phytochemicals from
Mangifera pajang Kosterm and their biological activities. BMC
Complement Altern Med. 15(83)2015.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Razak S, Afsar T, Ullah A, Almajwal A,
Alkholief M, Alshamsan A and Jahan S: Taxifolin, a natural
flavonoid interacts with cell cycle regulators causes cell cycle
arrest and causes tumor regression by activating Wnt/β-catenin
signaling pathway. BMC Cancer. 18(1043)2018.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Ediriweera MK, Tennekoon KH, Samarakoon
SR, Thabrew I and De Silva ED: Cytotoxic and apoptotic effects of
the bark of two common mango (Mangifera indica) varieties
from Sri Lanka on breast and ovarian cancer cells. Br J Pharm Res.
10:1–7. 2016.
|
|
74
|
Ferhi S, Santaniello S, Zerizer S,
Cruciani S, Fadda A, Sanna D, Dore A, Maioli M and D'hallewin G:
Total phenols from grape leaves counteract cell proliferation and
modulate apoptosis-related gene expression in MCF-7 and HepG2 human
cancer cell lines. Molecules. 24(612)2019.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Scarlatti F, Maffei R, Beau I, Codogno P
and Ghidoni R: Role of non-canonical Beclin 1-independent autophagy
in cell death induced by resveratrol in human breast cancer cells.
Cell Death Differ. 15:1318–1329. 2008.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Jo EH, Lee SJ, Ahn NS, Park JS, Hwang JW,
Kim SH, Aruoma OI, Lee YS and Kang KS: Induction of apoptosis in
MCF-7 and MDA-MB-231 breast cancer cells by Oligonol is mediated by
Bcl-2 family regulation and MEK/ERK signaling. Eur J Cancer Prev.
16:342–347. 2007.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Morré DM and Morré DJ: Anticancer activity
of grape and grape skin extracts alone and combined with green tea
infusions. Cancer Lett. 238:202–209. 2006.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Schuebel K, Gitik M, Domschke K and
Goldman D: Making sense of epigenetics. Int J Neuropsychopharmacol.
19(pyw058)2016.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Szyf M and Meaney MJ: Epigenetics,
behaviour, and health. Allergy Asthma Clin Immunol. 4:37–49.
2008.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Hamilton JP: Epigenetics: Principles and
practice. Dig Dis. 29:130–135. 2011.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Rozek LS, Dolinoy DC, Sartor MA and Omenn
GS: Epigenetics: Relevance and implications for public health. Annu
Rev Public Health. 35:105–122. 2014.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Moosavi A and Motevalizadeh Ardekani A:
Role of epigenetics in biology and human diseases. Iran Biomed J.
20:246–258. 2016.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Margueron R and Reinberg D: Chromatin
structure and the inheritance of epigenetic information. Nat Rev
Genet. 11:285–296. 2010.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Jones PA and Laird PW: Cancer epigenetics
comes of age. Nat Genet. 21:163–167. 1999.PubMed/NCBI View
Article : Google Scholar
|
|
85
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002.PubMed/NCBI View
Article : Google Scholar
|
|
86
|
Rauluseviciute I, Drabløs F and Rye MB:
DNA hypermethylation associated with upregulated gene expression in
prostate cancer demonstrates the diversity of epigenetic
regulation. BMC Med Genomics. 13(6)2020.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Liang TJ, Wang HX, Zheng YY, Cao YQ, Wu X,
Zhou X and Dong SX: APC hypermethylation for early diagnosis of
colorectal cancer: A meta-analysis and literature review.
Oncotarget. 8:46468–46479. 2017.PubMed/NCBI View Article : Google Scholar
|
|
88
|
McLaughlin SK, Olsen SN, Dake B, De Raedt
T, Lim E, Bronson RT, Beroukhim R, Polyak K, Brown M, Kuperwasser C
and Cichowski K: The RasGAP gene, RASAL2, is a tumor and metastasis
suppressor. Cancer Cell. 24:365–378. 2013.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Williams BP, Pignatta D, Henikoff S and
Gehring M: Methylation-sensitive expression of a DNA demethylase
gene serves as an epigenetic rheostat. PLoS Genet.
11(e1005142)2015.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Da Costa EM, McInnes G, Beaudry A and
Raynal NJ: DNA methylation-targeted drugs. Cancer J. 23:270–276.
2017.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Christman JK: 5-Azacytidine and
5-aza-2'-deoxycytidine as inhibitors of DNA methylation:
Mechanistic studies and their implications for cancer therapy.
Oncogene. 21:5483–5495. 2002.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Javaid N and Choi S: Acetylation- and
methylation-related epigenetic proteins in the context of their
targets. Genes (Basel). 8(196)2017.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Handy DE, Castro R and Loscalzo J:
Epigenetic modifications: Basic mechanisms and role in
cardiovascular disease. Circulation. 123:2145–2156. 2011.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Eberharter A and Becker PB: Histone
acetylation: A switch between repressive and permissive chromatin.
Second in review series on chromatin dynamics. EMBO Rep. 3:224–229.
2002.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Ropero S and Esteller M: The role of
histone deacetylases (HDACs) in human cancer. Mol Oncol. 1:19–25.
2007.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Shanmugam MK, Arfuso F, Arumugam S,
Chinnathambi A, Jinsong B, Warrier S, Wang LZ, Kumar AP, Ahn KS,
Sethi G and Lakshmanan M: Role of novel histone modifications in
cancer. Oncotarget. 9:11414–11426. 2018.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Ju R and Muller MT: Histone deacetylase
inhibitors activate p21(WAF1) expression via ATM. Cancer Res.
63:2891–2897. 2003.PubMed/NCBI
|
|
98
|
Shamloo U and Usluer S: p21 in cancer
research. Cancers (Basel). 11(1178)2019.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Ediriweera MK and Cho SK: Targeting miRNAs
by histone deacetylase inhibitors (HDACi): Rationalizing
epigenetics-based therapies for breast cancer. Pharmacol Ther.
206(107437)2020.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Suraweera A, O'Byrne KJ and Richard DJ:
Combination therapy with histone deacetylase inhibitors (HDACi) for
the treatment of cancer: Achieving the full therapeutic potential
of HDACi. Front Oncol. 8(92)2018.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Lau PW and MacRae IJ: The molecular
machines that mediate microRNA maturation. J Cell Mol Med.
13:54–60. 2008.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Wei JW, Huang K, Yang C and Kang CS:
Non-coding RNAs as regulators in epigenetics. Oncol Rep. 37:3–9.
2017.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Moutinho C and Esteller M: MicroRNAs and
epigenetics. Adv Cancer Res. 135:189–220. 2017.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Mazzio EA and Soliman KFA: HTP
Nutraceutical screening for histone deacetylase inhibitors and
effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and
Grapeseed (Vitis vinifera) in HeLa cells. Cancer Genomics
Proteomics. 14:17–34. 2017.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Nguyen DD and Chang S: Development of
novel therapeutic agents by inhibition of oncogenic MicroRNAs. Int
J Mol Sci. 19(65)2017.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Peng Y and Croce CM: The role of MicroRNAs
in human cancer. Signal Transduct Target Ther.
1(15004)2016.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Krutovskikh VA and Herceg Z: Oncogenic
microRNAs (OncomiRs) as a new class of cancer biomarkers.
Bioessays. 32:894–904. 2010.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Ciesielski O, Biesiekierska M and
Balcerczyk A: Epigallocatechin-3-gallate (EGCG) alters histone
acetylation and methylation and impacts chromatin architecture
profile in human endothelial cells. Molecules.
25(2326)2020.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Zhou H, Chen JX, Yang CS, Yang MQ, Deng Y
and Wang H: Gene regulation mediated by microRNAs in response to
green tea polyphenol EGCG in mouse lung cancer. BMC Genomics. 15
(Suppl 11)(S3)2014.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Ma Y, Liu Y, Ma Y, Jiang N, Wang L, Wang
B, Niu W, Hu Y, Lin Q and Yu B: Mangiferin relieves
lipopolysaccharide-induced injury by up-regulating miR-181a via
targeting PTEN in ATDC5 cells. Front Pharmacol.
11(137)2020.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Xiao J, Liu LI, Zhong Z, Xiao C and Zhang
J: Mangiferin regulates proliferation and apoptosis in glioma cells
by induction of microRNA-15b and inhibition of MMP-9 expression.
Oncol Rep. 33:2815–2820. 2015.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Alberdi E, Sánchez-Gómez MV, Ruiz A,
Cavaliere F, Ortiz-Sanz C, Quintela-López T, Capetillo-Zarate E,
Solé-Domènech S and Matute C: Mangiferin and Morin attenuate
oxidative stress, mitochondrial dysfunction, and neurocytotoxicity,
induced by amyloid beta oligomers. Oxid Med Cell Longev.
2018(2856063)2018.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Lemus-Molina Y, Sánchez-Gómez MV,
Delgado-Hernández R and Matute C: Mangifera indica L.
extract attenuates glutamate-induced neurotoxicity on rat cortical
neurons. Neurotoxicology. 30:1053–1058. 2009.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Ajila CM, Rao LJ and Rao UJ:
Characterization of bioactive compounds from raw and ripe
Mangifera indica L. peel extracts. Food Chem Toxicol.
48:3406–3411. 2010.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Muruganandan S, Gupta S, Kataria M, Lal J
and Gupta PK: Mangiferin protects the streptozotocin-induced
oxidative damage to cardiac and renal tissues in rats. Toxicology.
176:165–173. 2002.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Rajendran P, Ekambaram G and Sakthisekaran
D: Effect of mangiferin on benzo(a)pyrene induced lung
carcinogenesis in experimental Swiss albino mice. Nat Prod Res.
22:672–680. 2008.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Wang RR, Gao YD, Ma CH, Zhang XJ, Huang
CG, Huang JF and Zheng YT: Mangiferin, an anti-HIV-1 agent
targeting protease and effective against resistant strains.
Molecules. 16:4264–4277. 2011.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Takeda T, Tsubaki M, Kino T, Yamagishi M,
Iida M, Itoh T, Imano M, Tanabe G, Muraoka O, Satou T and Nishida
S: Mangiferin induces apoptosis in multiple myeloma cell lines by
suppressing the activation of nuclear factor kappa B-inducing
kinase. Chem Biol Interact. 251:26–33. 2016.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Biersack B: Current state of phenolic and
terpenoidal dietary factors and natural products as non-coding
RNA/microRNA modulators for improved cancer therapy and prevention.
Noncoding RNA Res. 1:12–34. 2016.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Paolini A, Curti V, Pasi F, Mazzini G,
Nano R and Capelli E: Gallic acid exerts a protective or an
anti-proliferative effect on glioma T98G cells via dose-dependent
epigenetic regulation mediated by miRNAs. Int J Oncol.
46:1491–1497. 2015.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Sundaram KM, Hussain A, Haque S, Raina R
and Afroze N: Quercetin modifies 5'CpG promoter methylation and
reactivates various tumor suppressor genes by modulating epigenetic
marks in human cervical cancer cells. J Cell Biochem.
120:18357–18369. 2019.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Bishayee K, Khuda-Bukhsh AR and Huh SO:
PLGA-loaded Gold-nanoparticles precipitated with quercetin
downregulate HDAC-Akt activities controlling proliferation and
activate p53-ROS crosstalk to induce apoptosis in hepatocarcinoma
cells. Mol Cells. 38:518–527. 2015.PubMed/NCBI View Article : Google Scholar
|
